期刊
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
卷 168, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ejps.2021.106058
关键词
Oral delivery; Lipophilic drugs; Self-nanoemulsifying drug delivery systems; Bioavailability; Pharmacokinetics
资金
- MITACS Canada
The number of lipophilic drug candidates in pharmaceutical discovery pipelines has increased, leading to the need for improved formulation strategies. In this study, self-nanoemulsifying drug delivery systems (SNEDDS) were used to enhance the oral bioavailability of cannabidiol (CBD). The results showed that the SNEDDS formulations led to more rapid absorption and improved systemic exposure of CBD compared to traditional oil-based formulations.
The number of lipophilic drug candidates in pharmaceutical discovery pipelines has increased in recent years. These drugs often possess physicochemical properties that result in poor oral bioavailability, and their clinical potential may be limited without adequate formulation strategies. Cannabidiol (CBD) is an excellent example of a highly lipophilic compound with poor oral bioavailability, due to low water solubility and extensive first-pass metabolism. An approach that may overcome these limitations is formulation of the drug in self-nanoemulsifying drug delivery systems (SNEDDS). Herein, CBD-SNEDDS formulations were prepared and evaluated in vitro. Promising formulations (F2, F4) were administered to healthy female Sprague-Dawley rats via oral gavage (20 mg/kg CBD). Resulting pharmacokinetic parameters of CBD were compared to those obtained following administration of CBD in two oil-based formulations: a medium-chain triglyceride oil vehicle (MCT-CBD), and a sesame oil-based formulation similar in composition to an FDA-approved formulation of CBD, Epidiolex (R) (SO-CBD). Compared to MCT-CBD, administration of the SNEDDS formulations led to more rapid absorption of CBD (median Tmax values: 0.5 h (F2), 1 h (F4), 6 h (MCT-CBD)). Administration of F2 and F4 formulations also improved the systemic exposure to CBD by 2.2 and 2.8-fold compared to MCT-CBD; however, no improvement was found compared to SO-CBD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据